|
EP3793432A1
|
|
Dynamic angiographic imaging
|
|
WO2019195941A1
|
|
Dna methylation assays and methods
|
|
WO2018184115A1
|
|
Quinazolinone derivatives useful for imaging
|
|
CA2991987A1
|
|
Methods of determining urinary calculi composition
|
|
WO2017059548A1
|
|
Regulation of cell to cell connections
|
|
WO2016191865A1
|
|
Peptidomimetics for imaging the ghrelin receptor
|
|
EP3307378A1
|
|
Intratumoral modulation therapy
|
|
EP3271383A1
|
|
Stapled peptides and uses thereof
|
|
CA2980376A1
|
|
Metabolomics profiling of central nervous system injury
|
|
US2019043198A1
|
|
Automated segmentation of histological sections for vasculature quantification
|
|
US2017027973A1
|
|
Modularion of invariant natural killer t cells in the treatment of sepsis
|
|
CA2929014A1
|
|
Method and apparatus for analyzing three-dimensional image data of a target region of a subject
|
|
CA2916989A1
|
|
Inhibition of microrna for treatment of sepsis
|
|
EP2997137A1
|
|
Expandable cell populations from brain biopsies of living subjects
|
|
CA2848895A1
|
|
Treatment of compartment syndrome
|
|
WO2014153661A1
|
|
Method for detecting and monitoring bone loss
|
|
WO2014146202A1
|
|
Bacteria for the prevention, treatment and diagnosis of breast cancer
|
|
KR20140142733A
|
|
Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
|
|
CA2865830A1
|
|
Kinetic deconvolution optical reconstruction method
|
|
CN103260647A
|
|
EGFR antagonist for the treatment of heart disease
|
